Robot-assisted modified bilateral dismembered V-shaped flap pyeloplasty for ureteropelvic junction obstruction in horseshoe kidney using KangDuo-Surgical-Robot-01 system.

Journal: International braz j urol : official journal of the Brazilian Society of Urology
Published Date:

Abstract

PURPOSE: Horseshoe kidney (HSK) is the most common renal fusion anomaly, occurring in 0.25% of the population (1). It presents technical obstacles to pyeloplasty for ureteropelvic junction obstruction (UPJO) despite robotic assistance (2, 3). KangDuo-Surgical-Robot-01 (KD-SR-01), an emerging robotic platform in China, has yielded satisfactory outcomes in pyeloplasty (4, 5). We first describe our modified technique of robotic bilateral pyeloplasty for UPJO in HSK using KD-SR-01 system in the Lithotomy Trendelenburg position.

Authors

  • Zhenyu Li
    Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Xinfei Li
    Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Shubo Fan
    Department of Urology, Peking University First Hospital. Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Kunlin Yang
    Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Chang Meng
    Department of Urology, Peking University First Hospital. Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Shengwei Xiong
    Department of Urology, Peking University First Hospital. Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Silu Chen
    Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Zhihua Li
    Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
  • Xuesong Li
    Department of Chemistry, University of Wyoming, Laramie, WY, United States.